CN116693373A - Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof - Google Patents
Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof Download PDFInfo
- Publication number
- CN116693373A CN116693373A CN202310448560.2A CN202310448560A CN116693373A CN 116693373 A CN116693373 A CN 116693373A CN 202310448560 A CN202310448560 A CN 202310448560A CN 116693373 A CN116693373 A CN 116693373A
- Authority
- CN
- China
- Prior art keywords
- macrocyclic
- compound
- mapped
- chiral binaphthyl
- arene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004945 aromatic hydrocarbons Chemical class 0.000 title claims abstract description 26
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 title description 5
- 238000010189 synthetic method Methods 0.000 title description 2
- -1 iodine anions Chemical class 0.000 claims abstract description 29
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 19
- 239000011630 iodine Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 17
- SQTUYFKNCCBFRR-UHFFFAOYSA-N (2,4-dimethoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(OC)=C1 SQTUYFKNCCBFRR-UHFFFAOYSA-N 0.000 claims description 7
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 7
- 229920002866 paraformaldehyde Polymers 0.000 claims description 7
- 230000002194 synthesizing effect Effects 0.000 claims description 6
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 3
- 239000003068 molecular probe Substances 0.000 claims description 3
- 238000006482 condensation reaction Methods 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- IYAMYECUTLASCU-UHFFFAOYSA-L disodium;ethanol;carbonate Chemical compound [Na+].[Na+].CCO.[O-]C([O-])=O IYAMYECUTLASCU-UHFFFAOYSA-L 0.000 claims 1
- 150000001450 anions Chemical class 0.000 abstract description 22
- 230000008859 change Effects 0.000 abstract description 9
- 229910020366 ClO 4 Inorganic materials 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 5
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 238000005481 NMR spectroscopy Methods 0.000 description 13
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 13
- 230000003993 interaction Effects 0.000 description 13
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 12
- 230000007935 neutral effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000010668 complexation reaction Methods 0.000 description 6
- 238000001308 synthesis method Methods 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000536 complexating effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000001142 circular dichroism spectrum Methods 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002678 macrocyclic compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical class CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- UUZJJNBYJDFQHL-UHFFFAOYSA-N 1,2,3-triazolidine Chemical compound C1CNNN1 UUZJJNBYJDFQHL-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 102000006533 chordin Human genes 0.000 description 1
- 108010008846 chordin Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000018406 regulation of metabolic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/90—Ring systems containing bridged rings containing more than four rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Plasma & Fusion (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses chiral binaphthyl-mapped macrocyclic arene, and a preparation method and application thereof. Chiral binaphthyl-mapped macrocyclic aromatic compounds have the following structural formulas RR-1 and SS-1:the selective recognition of iodine anions is better than that of AcO ‑ 、NO 3‑ 、ClO 4 ‑ 、HSO 4 ‑ 、Br ‑ 、PF 6 ‑ 、H 2 PO 4 ‑ 、BF 4 ‑ 、CO 3 F 3 S ‑ The plasma anions, and the identification process can generate macroscopic color change, and can be used for detecting iodine anions.
Description
Technical Field
The invention relates to a macrocyclic arene, in particular to a chiral binaphthyl-mapped macrocyclic arene, a synthesis method thereof and application of the chiral binaphthyl-mapped macrocyclic arene as a molecular probe in detection of iodine anions in a solution system, and belongs to the technical field of small organic molecular materials.
Background
Negative ions are ubiquitous and play an important role in the human body. For example, iodine is a raw material for synthesizing thyroid hormone, and can promote metabolism of substances, regulate metabolism of proteins, fats and sugars, and contribute to regulation of metabolism of water and salts. However, iodine deficiency can lead to goiter or hypothyroidism. However, the most common effects of periodate on thyroid function are iodinated goiter (IH) and periodate hyperthyroidism. In addition, in the case of the optical fiber, 129 I - and 130 the radioisotope of I-is considered to be harmful to the environment. Therefore, the development of an iodine anion receptor and a sensor for detecting iodine anions has great value and has attracted considerable interest.
The development of supermolecular chemistry is driven by the continuous synthesis of novel macrocyclic host molecules and their unique molecular recognition properties. Over the past few decades, various macrocyclic hosts have been developed and exhibit excellent recognition properties for anions such as fluoride, nitrate, oxyacids and other anions. Prominent examples are Sessler's cuppyrrole, farnham's fluorinated macrocyclic ether, flood's triazolidine, sindbusiil macrocycle of Sindelar, beer's rotaxane and chordin, etc. Most strategies involve the incorporation of anions by utilizing hydrogen bonding provided by specific binding sites, thereby providing size and shape selectivity in a variety of media. However, there are relatively few reports of building up the macrocyclic ring of the iodonium anion receptor, because the iodonium anion has a large diameter and a low electron density, and it is difficult to form hydrogen bonds and anion-pi interactions. The literature (Angew.Chem., int.Ed.,2008,47,788;Angew.Chem, int.Ed.,2008,47,2649;Angew.Chem, int. Ed.,
2008,47,3740; J.am.chem.Soc.,2008,130,10895.) elucidates neutral C-H … anion interactions, which have attracted great interest and rapid development by chemists. Literature
(Science,2019,365,159;Chem.Soc.Rev.,2010,39,1262;Chem.Commun.,
2012,48,5065.) discloses triazole macrocycles and cages, and it was found that these exhibit strong affinity for anions through neutral C-H … anion interactions. Literature (Org).
Lett.,2020,22,4878;J.Am.Chem.Soc.,2020,142,20182;Angew.Chem.Int.
Ed.,2022, e 202209778.) reports the recognition of anions in water by molecular cages through neutral C-H … anion interactions. Literature (org.lett., 2016,18,5054.) demonstrates that pre-organized rigid macrocyclic [4] carbazoles can act as iodide anion receptors through neutral C-H … anion interactions. Despite these pioneering reports, macrocyclic host molecules with selective recognition of iodide anions have been rarely reported.
Disclosure of Invention
Aiming at the defects of the prior art, the first object of the invention is to provide chiral binaphthyl enantiomer macrocyclic arene which has a large number of neutral aryl C-H bonds and a special cavity structure, has selective recognition and complexation effects on iodine anions, has macroscopic color change after complexing the iodine anions, and is particularly suitable for detecting the iodine anions in a solution system.
The second aim of the invention is to provide a synthesis method of chiral binaphthyl-mapped macrocyclic arene, which is simple, mild in condition and high in yield, and is beneficial to expanding production.
A third object of the present invention is to provide the use of a chiral binaphthyl-mapped macrocyclic aromatic hydrocarbon comprising AcO - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - The iodine anions in the solution system of the plasma anions have selective recognition and complexation effects, and the color change visible to naked eyes after the iodine anions are complexed can be used for detecting the iodine anions in the solution system.
In order to achieve the above technical object, the present invention provides a chiral binaphthyl-enantiomer macrocyclic arene comprising RR-1 and/or SS-1 compounds;
the chiral binaphthyl-enantiomer macrocyclic aromatic hydrocarbon RR-1 and SS-1 provided by the invention have box-shaped structures, the cavity sizes are about 10.100 multiplied by 9.000 and 9.000 multiplied by 9.000 respectively, and RR-1 and SS-1 both contain a large number of neutral aryl C-H bonds and can be used as an iodine anion receptor to realize complexation of iodine anions, and particularly, the chiral binaphthyl-enantiomer macrocyclic aromatic hydrocarbon RR-1 and SS-1 have selective recognition effect on complex anion solution systems, and the RR-1 and SS-1 compounds have obvious macroscopic color change after complexing the iodine anions, so that the RR-1 and SS-1 compounds can be used for detecting the iodine anions.
The invention also provides a synthesis method of chiral binaphthyl-mapped macrocyclic arene, which comprises the steps of carrying out a suzuki coupling reaction on 2, 4-dimethoxy phenylboronic acid and an R-3 or S-3 compound to obtain the R-2 or S-2 compound; r-2 or S-2 and paraformaldehyde are subjected to condensation reaction to obtain RR-1 or SS-1 structural compounds;
the structural formula of the R-3 compound is as follows:
the structural formula of the S-3 compound is as follows:
the structural formula of the R-2 compound is as follows:
the structural formula of the S-2 compound is as follows:
the synthesis method of chiral binaphthyl enantiospecific macrocyclic arene can be realized through two-step reactions of suzuki coupling and condensation, and has the advantages of simple synthesis method and higher product yield.
As a preferred embodiment, the 2, 4-dimethoxyphenylboronic acid and the R-3 or S-3 compound are combined in Pd (PPh) 3 ) 4 And reacting for 12-36 hours at the temperature of 85-95 ℃ under the catalysis of CuI. Further preferably, the reaction is carried out at a temperature of 90℃for 24 hours.
As a more preferable scheme, the molar ratio of sodium carbonate to R-3 or S-3 compound is 1 (2-3).
As a more preferable embodiment, the molar ratio of 2, 4-dimethoxyphenylboronic acid to R-3 or S-3 compound is 1 (2-2.5).
As a more preferable embodiment, pd (PPh 3 ) 4 And CuI is added in catalytic amounts, for example 5 to 20mol%.
As a preferred scheme, in a dichloromethane solution system, the R-2 or S-2 compound and paraformaldehyde are reacted for 0.4 to 0.6 hours at room temperature under the catalysis of boron trifluoride diethyl ether. The addition amount of boron trifluoride diethyl etherate is 1 to 1.5 times of the molar amount of R-2 or S-2.
As a more preferred embodiment, the molar ratio of the R-2 or S-2 compound to paraformaldehyde is 1 (2 to 4).
The specific synthetic route of the chiral binaphthyl-mapped macrocyclic arene is as follows:
the invention also provides an application of the chiral binaphthyl-mapped macrocyclic arene as a molecular probe in detection of iodine anions in a solution system. The selective recognition effect of chiral binaphthyl-mapped macrocyclic aromatic hydrocarbon on iodine negative ions is obviously superior to that of other anions, such as AcO - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - Etc., and the identification process may be visually observed, such as a change in color of the solution from colorless to light orange. Compared with the prior art, the technical scheme of the invention has the beneficial technical effects that:
the chiral binaphthyl-mapped macrocyclic aromatic hydrocarbon provided by the invention has a large number of neutral aryl C-H bonds and a special cavity structure, and has selective recognition and complexation effects on iodine anions, such as those containing AcO - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - The solution system of the plasma anions can be used for identifying and complexing the iodide anions with high selectivity and generating macroscopic color change, and can be used for detecting the iodide anions in the solution system.
The synthesis method of chiral binaphthyl-mapped macrocyclic arene is simple, mild in condition and high in yield, and is beneficial to expansion of production.
Drawings
FIGS. 1 a) and b) are energy minimization structures of RR-1 and SS-1 simulated by a Gaussian computer program; c) CD spectra for RR-1 (black line) and SS-1 (red line).
In FIG. 2 a) is RR-1 (1.00X 10) -2 mM) in chloroform mixed solution, RR-1 and TBAX (X=AcO) - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、I - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - ) (5.0 equivalents); b) Is SS-1 (1.00X 10) -2 mM) in chloroform mixed solution, SS-1 and TBAX (x=aco - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、I - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - ) (5. Equivalent), the illustrations show photographs of the colors of these mixed solutions。
FIG. 3 a) is free RR-1 and b) is part of RR-1 1 H NMR spectrum (400 MHz, CDCl) 3 298K), 1.0 equivalent, c) is free TBAI, [ RR-1 ]] 0 =4.0mmol/L。
FIG. 4 is a Gaussian computer program modeling the energy minimization structures of RR-1/iodide and SS-1/iodide.
FIG. 5 shows RR-1 and SS-1 compounds 1 H NMR 13 C NMR。
Detailed Description
The following specific examples are intended to further illustrate the present invention, but not to limit the scope of the claims.
In the examples below, all reactions were carried out in oven-dried glassware. Commercial reagents were used without further purification. The chromatographic column adopts 100-200 mesh silica gel for separation.
R-3 and S-3 in the examples below were prepared according to the literature (org. Biomol. Chem.; 2011,9,2938.).
Example 1
R-3 (4.70 g,10 mmol), na 2 CO 3 (2.96 g,28 mmol), 2, 4-dimethoxyphenylboronic acid (4.00 g,22 mmol), a catalytic amount of CuI (21 mg) and tetrakis (triphenylphosphine) palladium (320 mg) were added to a mixture containing 100mL of CH 3 CH 2 Stirring in a flask of OH in N 2 Stirring for 24h at 90 ℃ under protection. After evaporation of the solvent, the mixture was extracted with dichloromethane (3×50 mL) and washed successively with water and brine. Organic layer in anhydrous Na 2 SO 4 Dried over and evaporated. The mixture was separated by silica gel column chromatography using methylene chloride/petroleum ether (4:1) as eluent to give compound R-2 (3.99 g, yield 68%) as a yellow solid.
1 H NMR(400MHz,Chloroform-d)δ8.01(d,J=10.3Hz,4H),7.46(dd,J=17.5,8.9Hz,4H),7.36(d,J=8.4Hz,2H),7.19(d,J=8.8Hz,2H),6.61(d,J=7.6Hz,4H),3.88(s,6H),3.82(d,J=2.2Hz,12H). 13 C NMR(101MHz,CDCl 3 )δ160.2,157.6,155.0,133.6,132.9,131.5,129.5,129.3,128.6,127.8,124.9,123.7,119.6,114.3,104.7,99.0,57.0,55.6,55.5.HRMS(APCI)m/z:[M+H] + calcd for C 38 H 35 O 6 ,587.2434;found,587.2428.
Example 2
S-3 was used instead of R-3 in example 1, with the other conditions and steps being the same.
Compound S-2 was obtained as a yellow solid (4.10 g, yield 70%).
1 H NMR(400MHz,Chloroform-d)δ8.09–7.97(m,4H),7.46(dd,J=17.1,8.9Hz,4H),7.36(d,J=8.2Hz,2H),7.19(d,J=8.8Hz,2H),6.61(d,J=7.5Hz,4H),3.88(s,6H),3.86–3.73(m,12H). 13 C NMR(101MHz,CDCl 3 )δ160.2,157.6,155.0,133.6,132.9,131.5,129.5,129.3,128.6,127.8,124.9,123.7,119.6,114.3,104.7,99.0,57.0,55.56,55.5.HRMS(APCI)m/z:[M+H] + calcd for C 38 H 35 O 6 ,587.2434;found,587.2431.
Example 3
To a mixture of R-2 (1.17 g,2.0 mmol) and paraformaldehyde (180 mg,6.0 mmol) in dichloromethane (150 mL) was added boron trifluoride diethyl ether (0.3 mL,2.4 mmol). Stirring at room temperature for 0.5h, and adding 150ml of water to quench the reaction. The organic layer was separated using anhydrous MgSO 4 And (5) drying. The solvent was removed in vacuo and the residue was separated by silica gel column chromatography (eluent: 2:1 DCM/petroleum ether) to give RR-1 as a yellow solid product (538 mg, 45%).
1 H NMR(400MHz,Chloroform-d)δ7.90(d,J=9.0Hz,4H),7.84(s,4H),7.39(d,J=9.0Hz,4H),7.26(s,4H),7.01–6.93(m,8H),6.60(s,4H),3.97(s,4H),3.93(s,12H),3.81(s,12H),3.76(s,12H). 13 C NMR(101MHz,CDCl 3 )δ157.6,155.8,154.8,133.7,132.7,132.1,129.3,129.2,128.7,127.5,124.6,122.7,121.4,119.6,114.1,96.0,57.0,56.0,55.9,27.8.HRMS(APCI)m/z:[M+H] + calcd for C 78 H 69 O 12 ,1197.4789;found,1197.4785.
Example 4
S-2 was used instead of R-2 in example 1, with the other conditions and steps being the same.
Compound SS-1 was obtained as a yellow solid (491 mg, yield 41%).
1 H NMR(400MHz,Chloroform-d)δ7.90(d,J=9.0Hz,4H),7.83(s,4H),7.39(d,J=9.0Hz,4H),7.26(s,4H),7.01–6.93(m,8H),6.60(s,4H),3.97(s,4H),3.93(s,12H),3.81(s,12H),3.76(s,12H). 13 C NMR(101MHz,CDCl 3 )δ157.6,155.8,154.8,133.7,132.7,132.1,129.3,129.2,128.73,127.5,124.6,122.7,121.4,119.6,114.1,96.0,57.0,55.9,55.9,27.8.HRMS(APCI)m/z:[M+H] + calcd for C 78 H 69 O 12 ,1197.4789;found,1197.4785.
The structural formulas of SS-1 and SS-2 synthesized in example 3 and example 4 are as follows:
from FIG. 1 c) it can be seen that the CD spectra of RR-1 and SS-1 show mirror images, which provides strong evidence that the enantiomerically pure macrocycles are provided.
The structure of RR-1 and SS-1 was known from Gaussian 09, and 6-311G was chosen as the basis, as shown in FIGS. 1 a and b, with both RR-1 and SS-1 having box-like structures with cavity sizes of approximately 10.100X 9.000 and 9.000X 9.000, respectively.
As shown in FIG. 2 a, after 5.0 equivalents of tetrabutylammonium salt (TBAX, X=AcO) was added to the mixture using a commercially available tetrabutylammonium salt (TBAX) as an anion source - 、NO 3- 、ClO 4 - 、HSO 4 - 、Br - 、I - 、PF 6 - 、H 2 PO 4 - 、BF 4 - 、CO 3 F 3 S - ) RR-1 was added to chloroform and the solution containing RR-1 and TBAI changed color from colorless to pale orange while the other solutions remained colorless. This apparent color change indicates that interactions between RR-1 and TBAI may have occurred. Ultraviolet-visible spectrum experiments further revealed the interaction behavior of RR-1 with TBAX. After addition of 5.0 equivalents of TBAI, the absorption was significantly enhanced at 300nm and 350nm, and a new absorption band appeared at 375nm, indicating the formation of RR-1/iodide complex in solution. On the other hand, no change in absorption spectrum was observed after the addition of the other TBAX. All of the upper partsThe results indicate that RR-1 has the ability to selectively recognize iodide anions over other test anions. Similar to RR-1, SS-1 also showed selective recognition of iodide anions over other tested anions, as shown by b in FIG. 2.
RR-1 and TBAI in a molar ratio of 1:1 were mixed in CDCl 3 After that, in 1 A new set of proton signals different from RR-1 and TBAI were observed on the H NMR spectrum, indicating the formation of a new complex RR-1/iodide, as shown in FIG. 3. Protons b and e corresponding to RR-1 were shifted up by 0.006 and 0.004ppm, respectively, which may be attributed to the formation of neutral C-H … anionic interactions between RR-1 and TBAI. Only protons b and e corresponding to RR-1 are displaced, probably the recognition of iodide by RR-1 occurs outside the cavity. In addition, with ring [4]]The recognition of iodide by carbazole (which is a slow process occurring inside the cavity) is different, and the recombination and de-recombination between RR-1 and TBAI is a fast exchange process on the NMR time scale at room temperature. This difference may be due to the recognition of iodide by RR-1 through neutral C-H … anion interactions outside the cavity. To further understand the complexation process between RR-1 and TBAI, then proceed with 1 H NMR spectroscopic titration experiments. By monitoring the change in proton b corresponding to RR-1 after TBAI addition, a 1:1 complex was formed between RR-1 and TBAI by molar ratio mapping. Binding constant Ka for complex RR-1/iodide was 132.8.+ -. 33.8M as measured using BindFit software -1 . SS-1 and TBAI also formed a 1:1 complex of SS-1/iodide by the same method, and the binding constant was calculated as ka=
119.1±32.6M -1 。
The energy minimization optimization of RR-1/iodide and SS-1/iodide further supports the formation of neutral C-H … anion interactions. As shown in FIG. 4 a, the iodide anion is located outside the cavity of RR-1 by C-H … anion interactions, at distances 3.307 and 3.123, respectively. Only protons b and e corresponding to RR-1 are involved in hydrogen bond formation with the iodide anion, which is consistent with the shift of protons b and e in nmr hydrogen spectroscopy experiments. In the structure of complex SS-1/iodide, the iodide anion is also located outside the cavity of SS-1 by C-H … anion interaction, at distances 3.307 and 3.123, respectively, as shown in FIG. 4 b.
In conclusion, the invention successfully designs and synthesizes the chiral binaphthyl enantiomerically pure macrocyclic aromatic RR-1 and SS-1. RR-1 and SS-1 were tested for their ability to act as anion receptors by means of ultraviolet-visible spectrum and nuclear magnetic resonance hydrogen spectrum. RR-1 and SS-1 were found to be able to selectively bind iodide anions in a 1:1 manner. Of the 10 anions tested, neutral C-H. Anionic interactions play an important role in the formation of RR-1/iodine and SS-1/iodine anion complexes. The complexation of iodide with RR-1 or SS-1 was observed visually and the color of the solution changed from colorless to pale orange.
Claims (7)
1. A chiral binaphthyl-mapped macrocyclic aromatic hydrocarbon, characterized in that: comprising RR-1 and/or SS-1 compounds;
2. the method for synthesizing chiral binaphthyl-mapped macrocyclic arene according to claim 1, wherein the method comprises the following steps: 2, 4-dimethoxy phenylboronic acid and an R-3 or S-3 compound are subjected to suzuki coupling reaction to obtain an R-2 or S-2 compound; r-2 or S-2 and paraformaldehyde are subjected to condensation reaction to obtain RR-1 or SS-1 structural compounds;
the structural formula of the R-3 compound is as follows:
the structural formula of the S-3 compound is as follows:
the structural formula of the R-2 compound is as follows:
the structural formula of the S-2 compound is as follows:
3. the method for synthesizing chiral binaphthyl-mapped macrocyclic arene according to claim 2, wherein the method comprises the following steps: in sodium carbonate ethanol solution system, 2, 4-dimethoxy phenylboronic acid and R-3 or S-3 compound are mixed in Pd (PPh) 3 ) 4 And reacting for 12-36 hours at the temperature of 85-95 ℃ under the catalysis of CuI.
4. A method for synthesizing chiral binaphthyl-mapped macrocyclic aromatic hydrocarbon according to claim 3, characterized in that: the molar ratio of the sodium carbonate to the R-3 or S-3 compound is 1 (2-3);
the molar ratio of the 2, 4-dimethoxy phenylboronic acid to the R-3 or S-3 compound is 1 (2-2.5).
5. The method for synthesizing chiral binaphthyl-mapped macrocyclic arene according to claim 2, wherein the method comprises the following steps: in a dichloromethane solution system, the R-2 or S-2 compound and paraformaldehyde react for 0.4 to 0.6 hour at room temperature under the catalysis of boron trifluoride diethyl ether.
6. The method for synthesizing chiral binaphthyl-mapped macrocyclic arene according to claim 5, wherein the method comprises the following steps: the molar ratio of the R-2 or S-2 compound to the paraformaldehyde is 1 (2-4).
7. Use of a chiral binaphthyl-mapped macrocyclic arene according to claim 1, characterized in that: the method is used as a molecular probe for detecting iodine anions in a solution system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310448560.2A CN116693373A (en) | 2023-04-24 | 2023-04-24 | Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310448560.2A CN116693373A (en) | 2023-04-24 | 2023-04-24 | Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116693373A true CN116693373A (en) | 2023-09-05 |
Family
ID=87828302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310448560.2A Pending CN116693373A (en) | 2023-04-24 | 2023-04-24 | Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116693373A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115322201A (en) * | 2022-07-15 | 2022-11-11 | 湖南科技学院 | Macrocyclic column aromatic compound and preparation method and application thereof |
-
2023
- 2023-04-24 CN CN202310448560.2A patent/CN116693373A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115322201A (en) * | 2022-07-15 | 2022-11-11 | 湖南科技学院 | Macrocyclic column aromatic compound and preparation method and application thereof |
CN115322201B (en) * | 2022-07-15 | 2024-01-26 | 湖南科技学院 | Macrocyclic column aromatic compound, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Fluorescent sensors for amino acid anions based on calix [4] arenes bearing two dansyl groups | |
Kremers et al. | Synthesis and characterization of a chiral dendrimer derived from pentaerythritol | |
CN112062756B (en) | Stenhouse donor-acceptor adducts of mevalonate activated furan and 3-pyridylethylamine and methods of synthesizing the same | |
CN116693373A (en) | Chiral binaphthyl enantiomer macrocyclic arene, and synthetic method and application thereof | |
Gondal et al. | New alkoxymethyl-functionalized pyridinium-based chiral ionic liquids: Synthesis, characterization and properties | |
Li et al. | Novel enantioselective fluorescent sensors for malate anion based on acridine | |
CN114524948A (en) | 3D supramolecular material with various coordination configurations and preparation method and application thereof | |
CN108772027A (en) | The preparation and application of a kind of supramolecular organogel and its metal gel | |
CN111349121A (en) | Cobalt carbonyl complex and preparation method thereof | |
CN105884585A (en) | Method for preparing calix[4]arene fluorescent dye with solid light emission property | |
CN109369921A (en) | The preparation and application of multiple response supermolecule polymer gel with two-dimensional network structure | |
JP3950117B2 (en) | Molecular wire fluorescent chiral sensor | |
Bullough et al. | Tetrakis (methylimidazole) and tetrakis (methylimidazolium) calix [4] arenes: competitive anion binding and deprotonation | |
Thordarson et al. | The synthesis and studies towards the self-replication of bis (capped porphyrins) | |
Liu et al. | Synthesis and crystal structures of p-tert-butyldihomooxacalix [4] arene mono-Schiff bases | |
CN117736216B (en) | Trfoster's Base framework macrocyclic compound and preparation method and application thereof | |
Varghese et al. | Effect of chirality on the binding of viologen guests in porphyrin macrocycles | |
CN115650962B (en) | Fluorescent ligand compound for palladium catalytic coupling reaction and preparation method thereof | |
Georgiev et al. | Lower rim modification of calix [4] arenes to incorporate a single group functionality. Single crystal X-ray structures of 5-(3-bromopropyl)-25, 26, 27, 28-tetrahydroxycalix [4] arene and 25, 27-diallyloxy-26, 28-dibenzoyloxycalix [4] arene | |
CN117050331B (en) | Synthetic method of building column arene and terpyridine supermolecule crosslinked polymer | |
CN111484440B (en) | Indole triarylmethane derivative based on phenylboronic acid and synthetic method thereof | |
CN111484439B (en) | Indole triarylmethane derivative based on salicylaldehyde and synthetic method thereof | |
CN114643080B (en) | Olefin photodimerization catalyst and preparation method and application thereof | |
Han et al. | Complexation of Triptycene‐Derived Macrotricyclic Host with Bisparaquat Derivative and Self‐Folding Guest: A Switchable Process Controlled by K+ Ions | |
Xia et al. | Intramolecular cyclization strategy: synthesis of 1, 3-and 1, 2-calix [4] crown-7 and calix [4] crown-9 cone conformers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |